SCHEMBL4574501

SCHEMBL4574501

O=C1CN(Cc2ccccc2)C(=O)CN1CCCCCl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.45
▸ KMT2A Q03164 4/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ USP2 O75604 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ RECQL P46063 1/20 0.45
▸ BLM P54132 1/20 0.45
▸ ACHE P22303 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ PLA2G2A P14555 2/20 0.43
▸ APP P05067 1/20 0.43
▸ HRH3 Q9Y5N1 1/20 0.43
▸ DRD3 P35462 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ ENPP2 Q13822 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ EPHX2 P34913 1/20 0.41
▸ HDAC6 Q9UBN7 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16081232 0.86 SSTR4 (0.48) MEN1KMT2AKDM4EUSP2POLB
SCHEMBL1488276 0.84 L3MBTL1 (0.56) MEN1KMT2APOLBL3MBTL1DRD3
SCHEMBL16081239 0.84 SIGMAR1 (0.45) MEN1KMT2AKDM4EUSP2POLB
SCHEMBL16081233 0.84 SIGMAR1 (0.45) MEN1KMT2AKDM4EUSP2POLB
SCHEMBL10976738 0.83 MEN1 (0.56) MEN1KMT2AKDM4EUSP2POLB
SCHEMBL16081245 0.81 SIGMAR1 (0.43) MEN1KMT2AKDM4EUSP2POLB
SCHEMBL16081243 0.81 SIGMAR1 (0.43) MEN1KMT2AKDM4EUSP2POLB
SCHEMBL16081231 0.80 SSTR4 (0.44) MEN1KMT2AKDM4EUSP2POLB
SCHEMBL16081227 0.79 PLA2G2A (0.48) MEN1KMT2APOLBACHEL3MBTL1
SCHEMBL16085590 0.78 KMT2A (0.49) MEN1KMT2AACHEL3MBTL1DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008047883-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENES FOR TREATMENT OF MENTAL DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-04-24 — — WO disclosed
Send feedback